Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jan 1;125(1):10-1.
doi: 10.1182/blood-2014-11-611780.

ST2: the biomarker at the heart of GVHD severity

Sawa Ito  1 , A John Barrett  1
Affiliations
Comment

ST2: the biomarker at the heart of GVHD severity

Sawa Ito et al. Blood. .

Abstract

In this issue of Blood, Ponce et al report that high suppression of tumorigenicity 2 (ST2) levels are significantly associated with the incidence of acute graft-versus-host disease (aGVHD) and transplant-related mortality (TRM) in recipients of double-unit cord blood transplants (CBTs).

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Comment on

References

    1. Ponce DM, Hilden P, Mumaw C, et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 2015 125(1):199-205. - PMC - PubMed
    1. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39(6):1003–1018. - PMC - PubMed
    1. Vander Lugt MT, Braun TM, Hanash S, et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med. 2013;369(6):529–539. - PMC - PubMed
    1. Gatza E, Braun T, Levine JE, et al. Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20(9):1426–1434. - PMC - PubMed
    1. Yin F, Battiwalla M, Ito S, et al. Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses. Stem Cells. 2014;32(5):1278–1288. - PMC - PubMed

MeSH terms